BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 27485063)

  • 1. Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden.
    Ronot M; Cauchy F; Gregoli B; Breguet R; Allaham W; Paradis V; Soubrane O; Vilgrain V
    HPB (Oxford); 2016 Aug; 18(8):684-90. PubMed ID: 27485063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Preoperative Portal Vein Embolization Outcomes in Patients with Hepatocellular Carcinoma: A Single-Center Experience.
    Marti J; Giacca M; Alshebeeb K; Bahl S; Hua C; Horn JC; BouAyache J; Patel R; Facciuto M; Schwartz M; Florman S; Kim E; Gunasekaran G
    J Vasc Interv Radiol; 2018 Jul; 29(7):920-926. PubMed ID: 29735260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies.
    Peng PD; Hyder O; Bloomston M; Marques H; Corona-Villalobos C; Dixon E; Pulitano C; Hirose K; Schulick RD; Barroso E; Aldrighetti L; Choti M; Shen F; Kamel I; Geschwind JF; Pawlik TM
    HPB (Oxford); 2012 Aug; 14(8):523-31. PubMed ID: 22762400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
    Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
    World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis.
    Koh PS; Chan AC; Cheung TT; Chok KS; Dai WC; Poon RT; Lo CM
    HPB (Oxford); 2016 Jan; 18(1):72-8. PubMed ID: 26776854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
    Zhang DZ; Wei XD; Wang XP
    World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
    World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.
    Park GC; Lee SG; Yoon YI; Sung KB; Ko GY; Gwon DI; Jung DH; Jung YK
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):244-251. PubMed ID: 32414576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
    Jiang JH; Guo Z; Lu HF; Wang XB; Yang HJ; Yang FQ; Bao SY; Zhong JH; Li LQ; Yang RR; Xiang BD
    World J Gastroenterol; 2015 Apr; 21(15):4627-34. PubMed ID: 25914472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of large hepatocellular carcinoma by sequential transarterial chemoembolization and portal vein embolization: a systematic review of the literature.
    Piardi T; Memeo R; Renard Y; Ammendola M; Bruno O; Habersetzer F; Baumert T; Pessaux P; Sommacale D
    Minerva Chir; 2016 Jun; 71(3):192-200. PubMed ID: 26883849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection.
    Paik KY; Kim EK
    Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):158-64. PubMed ID: 27020632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma.
    Zhu SL; Zhong JH; Ke Y; Ma L; You XM; Li LQ
    World J Gastroenterol; 2015 Aug; 21(32):9630-7. PubMed ID: 26327771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
    Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF
    Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC.
    Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA; Wang LF
    Asian Pac J Cancer Prev; 2014; 15(2):703-6. PubMed ID: 24568482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.